Jessica Lee, MD
Obstetrics & Gynecology · Houston, TXNPI 1336334507
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations.
Across 110 payments — averaging $20.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$506
- Sumitomo Pharma America, Inc.$213
- AbbVie$170
- Mayne Pharma Commercial LLC$127
- Medtronic$115
- Coopersurgical, Inc.$110
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,24499%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 25 | $506 |
| Sumitomo Pharma America, Inc. | 10 | $213 |
| AbbVie | 8 | $170 |
| Mayne Pharma Commercial LLC | 7 | $127 |
| Medtronic | 2 | $115 |
| Coopersurgical, Inc. | 4 | $110 |
| Bayer | 4 | $102 |
| Evofem Biosciences, Inc. | 5 | $90 |
| Roche Diagnostics Corporation | 4 | $72 |
| American Orthodontics Corporation | 2 | $62 |
| Boston Scientific | 2 | $60 |
| Therapeuticsmd, Inc. | 3 | $55 |
| Allotrope Medical, Inc | 1 | $54 |
| Pfizer | 4 | $53 |
| Hologic Sales And Service, LLC | 2 | $51 |
| Biogen | 2 | $50 |
| Octapharma USA, Inc. | 1 | $40 |
| Avion Pharmaceuticals | 2 | $37 |
| Meditrina | 3 | $36 |
| Organon | 6 | $34 |
| Novo Nordisk | 2 | $31 |
| Duchesnay USA Incorporated | 1 | $24 |
| Axonics, Inc. | 1 | $22 |
| Mylan Pharmaceuticals Inc. | 1 | $21 |
| Smith+Nephew | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Heron Therapeutics, Inc. | 1 | $18 |
| AMAG Pharmaceuticals, Inc. | 1 | $17 |
| Medicem Inc. | 1 | $17 |
| Renovia Inc | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
| Myovant Sciences Inc. | 1 | $11 |
How this compares
$2,261 in reported general payments places this provider in the 70th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Houston
- George KuhnHouston$244K
- Daisy AyimHouston$188K
- Shannon WestinHouston$176K
- Asha BhalwalHouston$151K
- Nicole TranHouston$133K
- Sandra HurtadoHouston$123K
- Alvaro MontealegreHouston$92K
- Patti RossHouston$72K
- Damla KarsanHouston$58K
- Christopher JayneHouston$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.